Dr. Garabedian is an Assistant Professor in the Department of Population Medicine (DPM) in the Division of Health Policy and Insurance Research (HPI). Her research is focused on the robust evaluation of global and domestic health insurance reforms, health care delivery system reforms and pharmaceutical policies using quasi-experimental research methods and routinely collected health insurance claims datasets.

Julia Marcus, PhD, MPH is an infectious disease epidemiologist and Associate Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute, and Adjunct Faculty at The Fenway Institute.

Sruthi Adimadhyam is a Research Scientist in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. A pharmacoepidemiologist by training, her interests include evaluation and confirmation of post-marketing safety signals, comparative effectiveness research, and methods to mitigate bias in observational studies of newly approved medications. She currently works on the FDA-sponsored Sentinel Initiative monitoring post-marketing safety of regulated medical products. Dr.